Bausch + Lomb Indocollyre 0.1% Eye Drops

Indocollyre 0.1% is a specialized ophthalmic solution containing indometacin, a non-steroidal anti-inflammatory drug used to treat inflammation following eye surgery. The brand name Indocollyre is historically associated with Chauvin Pharmaceuticals, a laboratory with deep roots in France, which became part of the Bausch + Lomb portfolio.

Manufacturing of this specific product is heavily centered in France, particularly at the Chauvin factory in Aubenas, which is a key production site for Bausch + Lomb's European pharmaceutical supply. Despite its French heritage, the brand is now under the umbrella of Bausch + Lomb, which is headquartered in Canada. The company has undergone various ownership changes, including its acquisition by Bausch Health (formerly Valeant), but it was spun off into an independent publicly traded entity in 2022. It remains one of the world's largest suppliers of contact lenses, care products, and surgical instruments.